Adocia (OTCMKTS:ADOCY – Get Free Report) is anticipated to release its resultson Thursday, September 24th. Analysts expect Adocia to post earnings of ($0.6609) per share for the quarter.
Adocia Price Performance
ADOCY opened at $11.80 on Wednesday. The firm’s 50 day simple moving average is $11.80 and its two-hundred day simple moving average is $11.80. Adocia has a 1-year low of $9.80 and a 1-year high of $11.80. The company has a current ratio of 1.19, a quick ratio of 1.17 and a debt-to-equity ratio of 4.18.
About Adocia
Adocia is a biopharmaceutical company based in Lyon, France, focused on developing innovative formulations of therapeutic proteins and peptides. The company’s research is centered on its proprietary BioChaperone technology, which is designed to improve the solubility, stability, absorption and delivery of biologic medicines.
Adocia has primarily targeted diabetes and metabolic diseases, developing insulin-based treatments and combination therapies intended to improve blood-glucose management and patient convenience.
Recommended Stories
- Five stocks we like better than Adocia
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for Adocia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adocia and related companies with MarketBeat.com's FREE daily email newsletter.
